new_0222_0440|HOWL|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0440|HOWL|1|Werewolf Therapeutics Inc Total Current Assets (Quarterly) (USD)|Werewolf Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Werewolf Therapeutics Inc Inventories (Quarterly) (USD)|Werewolf Therapeutics Inc Net PP&E (Quarterly) (USD)|Werewolf Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Werewolf Therapeutics Inc Total Liabilities (Quarterly) (USD)|Werewolf Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Werewolf Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Werewolf Therapeutics Inc Total Deposits (Quarterly) (USD)|Werewolf Therapeutics Inc Book Value (Quarterly) (USD)|Werewolf Therapeutics Inc Retained Earnings (Quarterly) (USD)|Werewolf Therapeutics Inc Treasury Stock (Quarterly) (USD)|Werewolf Therapeutics Inc EV to Revenues|Werewolf Therapeutics Inc EV to Earnings|Werewolf Therapeutics Inc EV to Free Cash Flow|Werewolf Therapeutics Inc EV to Assets (Quarterly)|Werewolf Therapeutics Inc PS Ratio|Werewolf Therapeutics Inc PE Ratio|Werewolf Therapeutics Inc Price to Book Value|Werewolf Therapeutics Inc PEG Ratio|Werewolf Therapeutics Inc Debt to Equity Ratio|Werewolf Therapeutics Inc Dividend Yield|Werewolf Therapeutics Inc Shareholder Yield (TTM)|Werewolf Therapeutics Inc Percent of Shares Outstanding Short|Werewolf Therapeutics Inc Total Receivables (Quarterly) (USD)|Werewolf Therapeutics Inc Total Payables (Quarterly) (USD)|Werewolf Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Werewolf Therapeutics Inc Return on Invested Capital|Werewolf Therapeutics Inc Quality Ratio Score|Werewolf Therapeutics Inc Momentum Score|Werewolf Therapeutics Inc Beta (1Y)|Werewolf Therapeutics Inc Sustainable Growth Rate (TTM)|Werewolf Therapeutics Inc Institutional Investor Ownership Percentage|Werewolf Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Werewolf Therapeutics Inc Total Employees (Annual)|Werewolf Therapeutics Inc EPS Diluted (Quarterly) (USD)|Werewolf Therapeutics Inc SG&A Expense (Quarterly) (USD)|Werewolf Therapeutics Inc Shares Outstanding|Werewolf Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Werewolf Therapeutics Inc Ordinary Shares Number (Quarterly)|Werewolf Therapeutics Inc Payout Ratio|Werewolf Therapeutics Inc Quick Ratio (Quarterly)|Werewolf Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Werewolf Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Werewolf Therapeutics Inc Effective Tax Rate (TTM)|Werewolf Therapeutics Inc Return on Equity|Werewolf Therapeutics Inc Net Income (TTM) (USD)|Werewolf Therapeutics Inc Revenue (TTM) (USD)|Werewolf Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Werewolf Therapeutics Inc Revenue (Quarterly) (USD)|Werewolf Therapeutics Inc Gross Profit (Quarterly) (USD)|Werewolf Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Werewolf Therapeutics Inc Net Income (Quarterly) (USD)|Werewolf Therapeutics Inc Net Interest Income (Quarterly) (USD)|Werewolf Therapeutics Inc Price (USD)|Werewolf Therapeutics Inc Total Return Price (USD)|Werewolf Therapeutics Inc Enterprise Value (USD)|Werewolf Therapeutics Inc 30-Day Average Daily Volume|Werewolf Therapeutics Inc 1 Year Price Returns (Daily)|Werewolf Therapeutics Inc Short Interest|Werewolf Therapeutics Inc PE Ratio (Forward)|Werewolf Therapeutics Inc PE Ratio (Forward 1y)|Werewolf Therapeutics Inc PS Ratio (Forward)|Werewolf Therapeutics Inc PS Ratio (Forward 1y)|Werewolf Therapeutics Inc Quarterly EPS Estimates (USD)|Werewolf Therapeutics Inc Quarterly Revenue Estimates (USD)|Werewolf Therapeutics Inc Quarterly EPS Surprise|Werewolf Therapeutics Inc Quarterly Revenue Surprise|Werewolf Therapeutics Inc Quarterly Actual EPS (USD)|Werewolf Therapeutics Inc Quarterly Actual Revenue (USD)|Werewolf Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Werewolf Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Werewolf Therapeutics Inc Price Target (USD)|Werewolf Therapeutics Inc Consensus Recommendation|Werewolf Therapeutics Inc Price Target Num Estimates|Werewolf Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Werewolf Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Werewolf Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Werewolf Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Werewolf Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Werewolf Therapeutics Inc Land and Improvements (Quarterly) (USD)|Werewolf Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Werewolf Therapeutics Inc Other Properties (Quarterly) (USD)|Werewolf Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0440|HOWL|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0440|HOWL|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0440|HOWL|5|91|91||91||91|91|91||91|91||||1.44117647059||||1.43827160494|||1.44117647059||15.3333333333||91|91||||||31|91.3333333333|91.5|91.3333333333|91.3333333333|27.5714285714||91|||91.3333333333|91.4|||91|||||91.3333333333|91.3333333333|91.3333333333|1.44117647059|1.44117647059|1.44117647059|1.44||15.3333333333|||||91.4285714286|91.4285714286|91.5||91.5|91.5|182|182|25.25|11.2222222222|25.25|24.4285714286|30.3333333333|91.3333333333|91.3333333333|||90|91|||
new_0222_0440|HOWL|6|3|3||3||3|3|3||3|3||||204||||162|||204||18||3|3||||||1|6|2|6|6|7||3|||6|5|||3|||||6|6|6|204|204|204|175||18|||||7|7|2||2|2|1|1|8|18|8|7|6|6|6|||1|3|||
new_0222_0440|HOWL|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0440|HOWL|202003||||||||||||||||||||||||||||||||||8.9707||-0.4266|1.131||||||-0.4266|||||||||-3.827|-3.827|0.067||||||||||||||||||||||||2.763|0.023|||||||
new_0222_0440|HOWL|202006||||||||||||||||||||||||||||||||||8.9707||0.2481|1.285||||||0.2516|||||||||2.257|2.257|0.024||||||||||||||||||||||||3.78|0.042|||||||
new_0222_0440|HOWL|202009||||||||||||||||||||||||||||||||||8.9707||-0.6764|1.241||||||-0.6764|||||||||-6.068|-6.068|-0.015||||||||||||||||||||||||4.812|0.041|||||||
new_0222_0440|HOWL|202012|92.914|92.57||3.122||148.261|5.284|142.977||-51.863|-51.865|||||||||||||||1.021|0.002|||||||8.9707||-0.8217|2.106|||27.568|||-0.8251||||-15.04|||||-7.402|-7.402|0.028||||||||||||||||||||||||5.286|0.044|||2.471|0.606|0.032||
new_0222_0440|HOWL|202103|84.865|84.602||2.999||243.19|5.409|237.781||-153.754|-153.756||||-15.8228|||||||||3.0579||1.8|0.002||||||0.1133|26.2894|28|-3.8971|2.635|27.5394||27.568|||-0.2828||||-18.648|||||-7.435|-7.435|0.033|16.1|16.1|358.7823|||842137|||||-0.43||-765.1163||-3.72||||26.5|1.25|4|-1.4667|-2.0467|4.817|0.039|||2.305|0.694||14.88|
new_0222_0440|HOWL|202106|186.359|183.233||2.824||8.862|7.37|1.492||181.556|-221.268||||-10.2938||||2.6481|||||4.1938||3.193|0.002|||||||17.75|31|-3.82|3.691|27.568||27.568|||-3.82|-111.6|||-31.826|||||-10.921|-10.921|0.051|17.44|17.44|297.5529|162547.3333||1156155|||||-0.28||-1264.2857||-3.82||||26.5|1.25|4|-1.23|-2.06|7.265|0.062||||2.824||17.42|17.8
new_0222_0440|HOWL|202109|174.404|170.438||2.752||9.072|7.775|1.297||169.303|-235.026||||-8.1389||||2.7588|||||2.4367||1.457|0.002|||||||27.188|36|-0.51|4.008|27.219||27.219|||-0.51||||-39.516|||||-13.758|-13.758|0.037|17.16|17.16|296.64|15146.8||663251|||||-0.46||-10.8696||-0.51||||26.4|1.2|5|-4.7333|-2.1725|9.787|0.067||||2.752||15.67|14.49
new_0222_0440|HOWL|202112|||||||||||||||-4.336||||1.9401|||||2.8344|||||||||||||||||||||||||||||||11.91|11.91|158.0338|188805.9||781724|||||-0.5267||||||||26.2|1.2|5||||||||||9.11|6.93
new_0222_0440|HOWL|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.51|||||||||||||||||||||
new_0222_0440|HOWL|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.52|||||||||||||||||||||
new_0222_0440|HOWL|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.52|||||||||||||||||||||
new_0222_0440|HOWL|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.5|||||||||||||||||||||